Hosted by the Pharmacogenomics SIG.
Recently, the Board of Pharmacy Specialties (BPS) has begun the process of assessing the need for development of a pharmacogenomics certification. Given that approval of such a certification may impact many members of the Pharmacogenomics SIG, we believe our group would be interested in hearing from a panel of leaders in pharmacogenomics education on this topic.
Objectives:
- Describe the potential benefits and drawbacks of a pharmacogenomics BPS certification
- Identify how a BPS certificate in Pharmacogenomics may fit into the current advanced environment of advanced pharmacogenomics training offered through other venues, such as certificate programs and fellowships
Moderator:
Kristen Ward, PharmD, BCPP
Clinical Associate Professor
University of Michigan College of Pharmacy
Speakers:
Emily Cicali, PharmD, BCPS
Clinical Associate Professor
University of Florida College of Pharmacy
Jeffrey R. Bishop, PharmD, MS, BCPP, FCCP
Professor, Department of Experimental and Clinical Pharmacology (ECP)
Adjunct Associate Professor, Department of Psychiatry
University of Minnesota College of Pharmacy
Adrijana Kekic, PharmD, BCACP
Assistant Program Director, PGY-1 Community-Based Pharmacy Residency
Mayo Clinic Hospital